Company News »

Zeldes Haeggquist & Eck, LLP Announces Investigation of Celgene, Inc.

Business Wire
Share on StockTwits
Published on

Zeldes Haeggquist & Eck, LLP, a shareholder and consumer rights litigation firm, has commenced an investigation into possible breaches of fiduciary duty and other violations of law by certain officers and directors at Celgene, Inc. (“Celgene” or the “Company”).

Celgene (NASDAQ:CELG) is a pharmaceutical company based in New Jersey. The investigation focuses on allegations that the Company has marketed two of its top-selling cancer medicines for unapproved uses and made improper payments to doctors, and whether the Company’s top officers and directors were aware of these wrongdoings.

What You Can Do

If you are a Celgene shareholder, you may have legal claims against the officers and directors under the securities laws. If you wish to discuss this investigation, or have questions about this notice or your legal rights, please contact attorney Amber L. Eck at 619-342-8000, or by email at ambere@zhlaw.com. There is no cost to you.

About Zeldes Haeggquist & Eck, LLP

Zeldes Haeggquist & Eck, LLP is a full-service law firm which brings major class actions nationwide on behalf of defrauded investors and consumers and handles a variety of complex business litigation matters. Please visit www.zhlaw.com or our blog for more information about the firm.

Share on StockTwits

What others are reading on Finances

Sorry. No data so far.


Iron FX 1.11156/1.11128 2.8
XM Markets 1.09948/1.09928 2
FxPro 1.10184/1.10171 1.3
FXCM 1.13943/1.13912 3.1